• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8 filed

    12/29/20 10:07:10 AM ET
    $AMRH
    Semiconductors
    Technology
    Get the next $AMRH alert in real time by email
    8-K 1 form8-k.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of Earliest Event Reported): December 29, 2020

     

    Ameri Holdings, Inc.
    (Exact name of registrant as specified in its charter)

     

    Delaware   001-38286   95-4484725

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    5000 Research Court, Suite 750, Suwanee, Georgia   30024
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: (770) 935-4152

     

     
    (Former Name or Former Address, If Changed Since Last Report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class   Trading Symbol   Name of Each Exchange on Which Registered
    Common Stock $0.01 par value per share   AMRH   The NASDAQ Stock Market LLC
    Warrants to Purchase Common Stock   AMRHW   The NASDAQ Stock Market LLC

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    [  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company [X]

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

     

     

     

     
     

     

    Item 5.07. Submission of Matters to a Vote of Security Holders.

     

    Ameri Holdings, Inc. (the “Company”) held a special meeting of the stockholders (the “Special Meeting”) on December 29, 2020. The Special Meeting was originally adjourned on December 23, 2020.

     

    As of November 11, 2020, 2020, the record date for the Meeting, there were 7,441,320 shares of our common stock outstanding.

     

    At the Meeting, the stockholders voted on the following nine proposals and cast their votes as follows:

     

    1. To ratify the Ameri Share Issuance Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,916,886   118,333   41,682

     

    2. To ratify the Ameri Future Share Issuance Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,907,093   121,899   47,909

     

    3. To ratify the Reverse Stock Split Proposal.

     

    Votes For   Votes Against   Votes Abstained
    5,384,097   565,002   31,283

     

    -2-

     

     

    4. To ratify the Spin-Off Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,814,370   192,198   70,333

     

    5. To ratify the A&R Charter Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,859,044   162,832   55,025

     

    6. To ratify the Incentive Plan Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,737,483   284,429   54,989

     

    7. To ratify the Put Right Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,828,174   215,277   33,450

     

    8. To ratify the Bonus Shares Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,719,020   318,131   39,750

     

    9. To ratify the Conversion Proposal.

     

    Votes For   Votes Against   Votes Abstained
    3,794,393   219,303   63,205

     

    In connection with the approval of Proposal 9, the board of directors of the Company agreed to reduce the conversion price of the June Debenture from $1.75 to $1.00. In connection with the approval of Proposal 9, the board of directors of the Company agreed to reduce the conversion price of the June Debenture from $1.75 to $1.00. This Debenture has a current balance of principal and accrued interest through the date hereof of $728,812.92. This reduction is effective immediately.

     

    Item 8.01 Other Events

     

    On December 29, 2020, the Company issued a press release announcing the results of the Special Meeting. A copy of the press release is attached hereto as Exhibit 99.1.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    99.1   Press Release, dated December 29, 2020

     

    -3-

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    December 29, 2020 AMERI HOLDINGS, INC.
         
      By: /s/ Barry Kostiner
      Name:  Barry Kostiner
      Title: Chief Financial Officer

     

    -4-

     

     

    Get the next $AMRH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMRH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ameri Holdings Completes Spin-Off and Tender Offer, Changes Name to Enveric Biosciences and Begins Trading on the Nasdaq Under the Symbol "ENVB"

    NAPLES, Fla., Dec. 31, 2020 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), formerly AMERI Holdings, Inc. (NASDAQ: AMRH), a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments with novel cannabinoid medicines, announced the completion of the previously announced spin-off of the IT services business of the Company and the tender offer, whereby the Company purchased all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Company common stock, or if applicable, shares of Company preferred stock., and Jay Pharma became

    12/31/20 8:21:00 AM ET
    $AMRH
    Semiconductors
    Technology

    AMERI Holdings Announces 1-for-4 Reverse Stock Split

    ATLANTA, Dec. 30, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced a 1-for-4 reverse split of its common stock, effective as of 4:02 pm Eastern Time, December 30, 2020 (the "Reverse Stock Split"). As previously announced, at the special meeting of stockholders held on December 29, 2020, Ameri's stockholders approved all proposals to complete the proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement a

    12/30/20 12:59:00 PM ET
    $AMRH
    Semiconductors
    Technology

    AMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma Shares

    ATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August

    12/29/20 10:10:00 AM ET
    $AMRH
    Semiconductors
    Technology

    $AMRH
    SEC Filings

    View All

    SEC Form 8-K filed

    8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/15/21 4:16:05 PM ET
    $AMRH
    Semiconductors
    Technology

    SEC Form 424B5 filed

    424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/13/21 5:28:07 PM ET
    $AMRH
    Semiconductors
    Technology

    SEC Form 8-K/A filed

    8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)

    1/13/21 5:25:09 PM ET
    $AMRH
    Semiconductors
    Technology

    $AMRH
    Leadership Updates

    Live Leadership Updates

    View All

    AMERI Holdings' Stockholders Approve All Proposals To Complete Tender Offer For Jay Pharma Shares

    ATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August

    12/29/20 10:10:00 AM ET
    $AMRH
    Semiconductors
    Technology